Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
In this region, APAC Cancer Diagnostics Market is accounted to reach USD 7.10 billion by 2024 from USD 2.70 billion in 2016,it is growing at a CAGR of 12.7% in the forecast period 2017 to 2024
The major factors driving the growth of this market are the increasing medical tourism in Asia Pacific regions and technological development and increasing market reach by Asian countries.
The key market players for APAC Cancer Diagnostics Market are listed below:
• Hoffman-La Roche Ltd
• Abbott Laboratories Inc
• QIAGEN.
The market is further segmented into:
• Type
• Application
• Technology
• End User
• Geography
The APAC cancer diagnostics market is segmented on the basis of technology, application and geography. The APAC cancer diagnostics market is segmented into 2 types- platform based and instrument based.
In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2% and is expected to continue this trend till 2024.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.
Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Based on geography, the APAC Cancer Diagnostics Market is segmented into 11 geographical regions, such as,
• China,
• Japan,
• India,
• South Korea,
• Australia,
• Thailand,
• Malaysia,
• Singapore,
• Indonesia,
• Philippines
• Rest of APAC
Covered in this report
The report covers the present scenario and the growth prospects of the APAC Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are the increasing medical tourism in Asia Pacific regions and technological development and increasing market reach by Asian countries.
The key market players for APAC Cancer Diagnostics Market are listed below:
• Hoffman-La Roche Ltd
• Abbott Laboratories Inc
• QIAGEN.
The market is further segmented into:
• Type
• Application
• Technology
• End User
• Geography
The APAC cancer diagnostics market is segmented on the basis of technology, application and geography. The APAC cancer diagnostics market is segmented into 2 types- platform based and instrument based.
In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2% and is expected to continue this trend till 2024.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.
Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Based on geography, the APAC Cancer Diagnostics Market is segmented into 11 geographical regions, such as,
• China,
• Japan,
• India,
• South Korea,
• Australia,
• Thailand,
• Malaysia,
• Singapore,
• Indonesia,
• Philippines
• Rest of APAC
Covered in this report
The report covers the present scenario and the growth prospects of the APAC Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
